Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in hepatitis A control

L Yuan1

  • 1Department of Preventive Medicine and Biostatistics, University of Toronto.

Canadian Family Physician Medecin De Famille Canadien
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of Top Quark Production in Proton-Nucleus Collisions.

Physical review letters·2017
Same author

[Hypoxia inducible factor-1α deSUMOylation reduces the stemness maintenance ability of endometrial cancer stem cell and increases its chemosensitivity].

Zhonghua yi xue za zhi·2017
Same author

Measurements of the production cross section of a [Formula: see text] boson in association with jets in <i>pp</i> collisions at [Formula: see text] TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

[Comparative study on the efficacy and safety between pegfilgrastim (PEG-rhG-CSF) and recombinant human granulocyte colony-stimulating factor in promoting hematopoietic recovery after allogeneic hematopoietic stem cell transplantation after hematological malignancy].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2017
Same author

Phylogenetic and genetic variation analyses of porcine circovirus type 2 isolated from China.

Transboundary and emerging diseases·2017
Same author

[Research advances in the role of the Hippo signaling pathway in pathogenesis of liver cancer].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2017
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

A new inactivated hepatitis A vaccine is now available in Canada, marking a significant advancement in disease control. This development offers new strategies for preventing hepatitis A virus infection and managing the disease.

Area of Science:

  • Public Health
  • Vaccinology
  • Infectious Diseases

Background:

  • Hepatitis A represents a significant public health concern.
  • Control of hepatitis A has seen limited advancements over the past 50 years.

Purpose of the Study:

  • To introduce a newly licensed inactivated vaccine for hepatitis A in Canada.
  • To review the clinical and epidemiological aspects of hepatitis A.
  • To identify populations that could benefit from the new vaccine.

Main Methods:

  • Review of clinical and epidemiological data on hepatitis A.
  • Information on the newly licensed inactivated hepatitis A vaccine.
  • Analysis of potential recipient groups for vaccination.

Main Results:

Related Experiment Videos

  • A new inactivated vaccine for hepatitis A has been approved in Canada.
  • This vaccine represents a major breakthrough in hepatitis A control.
  • The article details vaccine information and target populations.

Conclusions:

  • The introduction of this inactivated hepatitis A vaccine is a pivotal moment in disease management.
  • Further understanding of hepatitis A epidemiology and clinical features is provided.
  • The vaccine offers a promising tool for preventing hepatitis A infection.